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ABSTRACT: Ribonucleotide reductases (RNRs) are respon-
sible for all de novo biosynthesis of DNA precursors in nature by
catalyzing the conversion of ribonucleotides to deoxyribonucleo-
tides. Because of its essential role in cell division, human RNR is
a target for a number of anticancer drugs in clinical use. Like
other class Ia RNRs, human RNR requires both a radical-
generation subunit (β) and nucleotide-binding subunit (α) for
activity. Because of their complex dependence on allosteric
eﬀectors, however, the active and inactive quaternary forms of
many class Ia RNRs have remained in question. Here, we
present an X-ray crystal structure of the human α subunit in the presence of inhibiting levels of dATP, depicting a ring-shaped
hexamer (α6) where the active sites line the inner hole. Surprisingly, our small-angle X-ray scattering (SAXS) results indicate that
human α forms a similar hexamer in the presence of ATP, an activating eﬀector. In both cases, α6 is assembled from dimers (α2)
without a previously proposed tetramer intermediate (α4). However, we show with SAXS and electron microscopy that at
millimolar ATP, the ATP-induced α6 can further interconvert with higher-order ﬁlaments. Diﬀerences in the dATP- and ATP-
induced α6 were further examined by SAXS in the presence of the β subunit and by activity assays as a function of ATP or dATP.
Together, these results suggest that dATP-induced α6 is more stable than the ATP-induced α6 and that stabilization of this ring-
shaped conﬁguration provides a mechanism to prevent access of the β subunit to the active site of α.
Found in all organisms, RNRs are complex allostericenzymes that supply precursors for DNA replication and
repair at controlled levels needed for maintaining the ﬁdelity of
these processes.1−3 Because of their essential role in DNA
biosynthesis, RNRs are excellent targets for anticancer, antiviral,
and antiparasitic drugs. In particular, human RNR is the target
for a number of inhibitors that are currently in clinical use for
chemotherapy.4,5 However, despite their medical importance,
the lack of structural information on the active and inactive
forms of many of these enzymes presents a major challenge in
the design of new therapeutics.
RNRs are classiﬁed by the metallocofactor essential for
initiating the intricate, radical-mediated mechanism of nucleo-
tide reduction.6,7 Eukaryotes and many aerobic bacteria utilize
class Ia RNRs, which require two subunits, α and β, for activity
(Figure 1A). α contains three nucleotide-binding sites, while β
harbors a diferric-tyrosyl radical cofactor (Y176• in human
RNR). For each turnover, the two subunits associate and
engage in a long-range radical transfer process over 35 Å,
involving multiple proton-coupled electron transfer (PCET)
steps and redox active amino acids. In this process, the Y•
cofactor in β oxidizes a conserved cysteine in the active site of α
to generate a thiyl radical that initiates nucleotide reduction via
a conserved mechanism.8 Class Ia RNRs can reduce any of the
four ribonucleoside 5′-diphosphates (ADP, CDP, UDP, GDP)
that bind to the active site of α, whereas substrate speciﬁcity is
controlled by the binding of deoxyribonucleoside 5′-triphos-
phates (dATP, TTP, dGTP) and adenosine triphosphate
(ATP) to an allosteric site in α known as the speciﬁcity site
(Figure 1A). Both ATP and dATP can promote CDP reduction
when bound to the speciﬁcity site. However, their binding at a
second allosteric site in the so-called N-terminal cone domain
of α modulates the overall rate of reduction (Figure 1A, green
domains). Binding of ATP at this activity site stimulates
nucleotide reduction, whereas dATP inactivates the enzyme.
Together, these allosteric sites act to maintain the proper
balance of intracellular deoxyribonucleotide pools.
In recent years, the role of the oligomerization state in the
allosteric regulation of class Ia RNRs has been a central
question.9−17 In all class Ia RNRs examined to date, β is a stable
dimer (β2). In the case of the most studied class Ia RNR from
Escherichia coli, α is also a dimer (α2) when eﬀectors are bound
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to the speciﬁcity site. Recent studies on E. coli RNR have
demonstrated that, as originally proposed,18 α2 and β2 assemble
into a compact but transient α2β2 complex, which is active for
turnover.9,14 In contrast, the binding of dATP at inhibitory
concentrations to the N-terminal cone domains leads to the
formation of an unusual ring-shaped α4β4 complex in E. coli
RNR,9,19 in which each β2 is held at “arm’s length” from the
active sites of α2, preventing radical transfer and hence
inhibiting the enzyme. However, despite structural homology
across all class Ia RNRs, eukaryotic RNRs do not form the same
quaternary structures as the E. coli enzyme. Early analytical
ultracentrifugation (AUC) studies showed that both ATP and
dATP induce higher order oligomers of mammalian RNRs
containing only the α subunit,20,21 in contrast to E. coli RNR,
which require both subunits to form oligomers.22,23 The role of
oligomerization in mammalian α was later revisited by
Cooperman and co-workers with dynamic light scattering
(DLS) and AUC. In these studies, they observed large
oligomers, which they attributed to α4 formation in the
presence of dATP and α6 in the presence of high ATP (10
mM).11,13 Although α tetramerization in eukaryotic RNRs has
not been reported since, α hexamerization has been reported in
the presence of both activating and inactivating eﬀectors by
multiple mass-estimation techniques, including size-exclusion
chromatography (SEC),10,12,15 gas-phase electrophoretic mobi-
lity analysis (GEMMA),16 and multiangle light scattering
(MALS).12 These observations have led to the proposal that
α6 can be active or inactive, depending on the eﬀectors that are
bound.12
Structural studies targeted at elucidating the quaternary
structure of eukaryotic RNRs have been challenging and thus
far limited to inhibitory conditions. Notably, in a recent study
by Fairman et al., cocrystallization of Saccharomyces cerevisiae α
with dATP led to a crystal lattice that could be formed by two
diﬀerent hexameric arrangements of α (Protein Data Bank or
PDB entry 3PAW), one in which three copies of α2 form a ring
with the active sites facing inward (Figure S1A) and another in
which three copies of α2 form an inverted structure with the
active sites facing outward (Figure S1B).12 In the same study,
mutagenesis on human α and electron microscopy (EM) data
on Saccharomyces cerevisiae α supported the ring-shaped
structure with the inward-facing active sites (Figure S1A) as
the dATP-inhibited form of α6. On the basis of mutagenesis
and tryptophan ﬂuorescence quenching data, it was further
proposed that the ATP-induced α6 conﬁguration would have a
diﬀerent packing arrangement than that formed with dATP.
However, no structural characterizations in the presence of
ATP were reported. Also, this study relied on the S. cerevisiae
enzyme for their structural studies of the α6 state.
In this present study, we investigate the quaternary structure
of human RNR using three complementary structural
techniques. We present the ﬁrst X-ray crystal structure of a
dATP-induced α6 from human RNR. The crystal lattice giving
rise to this structure supports only one hexameric arrangement,
in which the active sites face inward. By measuring small-angle
X-ray scattering (SAXS) at increasing concentrations of dATP
and ATP, we further provide evidence that this hexameric
arrangement forms in solution from the dimeric state in the
case of both eﬀectors. At high ATP concentrations (>1 mM),
however, the ATP-induced α6 readily interconverts with a
newly identiﬁed ﬁlament state, which we describe by both
SAXS and electron microscopy. Addition of β2 also promotes
large-scale structural changes to α6 in the presence of ATP, but
not dATP. Although the physiological relevance of the ﬁlament
state is not known, our results show that the human α subunit
can readily accommodate multiple structural states in the
presence of ATP and β2. These results support a uniﬁed
mechanism of allosteric inhibition for the class Ia RNRs, in
which dATP is the only eﬀector that favors stabilization of a
single conformation, one in which β2 likely has limited access to
the active sites of α6.
■ EXPERIMENTAL PROCEDURES
Protein Expression and Puriﬁcation. His6-tagged human
α and β were isolated using a modiﬁed procedure from
previous studies,10,15 while β was reconstituted following
published protocols with minor modiﬁcations.15 To remove
the N-terminal His6-tag from as-puriﬁed α, 2 U thrombin
(Novagen) was mixed with 1 mg α, followed by incubation at 4
°C for 6−8 h. Removal of the His6 tag was previously shown to
have a negligible eﬀect on the speciﬁc activity of α,10 and hence,
the tagged and untagged α constructs are interchangeable with
the one exception being the fraction of ﬁlaments at high ATP
concentration (as discussed in the Results). In the case of
human β, which is prone to proteolysis, the His6 tag was kept
intact to aid in the puriﬁcation of full-length β from fragments.
For additional details, see Supporting Information.
RNR Activity Assay. The activity of His6-tagged α or β was
determined by measuring the reduction of [5-3H] CDP in the
presence of 5-fold excess of the other subunit. To correlate
activity with the SAXS studies, 4 μM α (or β) was added to an
assay mixture containing 20 μM β (or α), 2 mM [5-3H] CDP, 3
mM ATP, 25 μM human thioredoxin 1 (hTrx1), 0.2 μM
human thioredoxin reductase 1 (hTrxR1), 2 mM NADPH in a
Figure 1. Structures of human RNR. (A) Each monomer of human α2
contains three nucleotide-binding sites (PDB: 3HNC, 3HND, 3HNE).
The activity-regulating site is housed in the N-terminal cone domain
(colored in green). Both the C-terminus and N-terminus are
disordered in structures of β2 (dotted lines, PDB: 2UW2). (B)
Crystal structure of human dATP-induced α6 determined in this study.
(C) Scattering from 4 μM α in the presence of 1 mM CDP yields an
ab initio shape reconstruction (yellow) that is consistent with the
crystal structure of human α2. (D) Scattering from 4 μM α in the
presence of 50 μM dATP and 1 mM CDP yields a shape
reconstruction (yellow) that is consistent with the crystal structure
of human α6.
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modiﬁed assay buﬀer (50 mM HEPES, 5% glycerol, 15 mM
MgCl2, 150 mM KCl, pH 7.6). Before mixing, all the
components were preincubated at 37 °C for 1 min. After
initiation by [5-3H] CDP addition, the 180-μL reaction mixture
was incubated at 37 °C for 2 min, and a 40-μL aliquot was
quenched by boiling for 2 min. Four aliquots were taken at 0.5,
1.0, 1.5, and 2.0 min, respectively. After centrifugation, the
supernatant (36 μL) was transferred to a new tube, and the
dephosphorylation reaction was performed by incubation at 37
°C for 2 h with 14 U calf alkaline phosphatase (Roche) and 400
nmol of carrier deoxycytidine (dC) in dephosphorylation buﬀer
(75 mM Tris-HCl, 0.15 mM EDTA, pH 8.5). The amount of
dC was quantiﬁed as described previously.24 In addition, for
assaying α at other concentrations (0.5, 1, 10 μM), the [α]:[β]
ratio was kept at 1:5 for all experiments to facilitate comparison
of α activities, while [CDP] was varied in order to ensure
substrate saturation (Table S1).
Crystallography. Protein solutions containing 12 mg/mL
His6-tagged α in 50 mM HEPES pH 7.6, 15 mM MgCl2, 100
mM KCl, 10 mM DTT, 5% v/v glycerol, 500 μM dATP, and 3
mM CDP were prepared on ice and incubated at 37 °C for 2
min. Crystallization experiments were then performed by
hanging drop vapor diﬀusion at 18 °C. Protein solution (1 μL)
was mixed with precipitant solution (1 μL) containing 100 mM
HEPES pH 7.0, 32% v/v Jeﬀamine M600, and 10 mM DTT
and suspended over a 400 μL reservoir of precipitant solution.
Crystals appeared within a week and were ﬂash cooled in liquid
N2 without additional cryoprotection. Diﬀraction images were
collected at the Cornell High Energy Synchrotron Source
(CHESS) F1 Station on an ADSC Quantum 270 CCD
detector, indexed and integrated with XDS, and scaled with
XSCALE (Table S2).25 The structure was solved to 9 Å
resolution by molecular replacement in Phaser26 using a
previously solved structure of α2 (3HNC chains A and B) with
all waters and ligands removed as the search model. A solution
with one α2 in the asymmetric unit was found. Reﬁnement at 9
Å resolution was performed in PHENIX27 using four atom
groups for both rigid body and group B-factor reﬁnement: for
each α chain, the N-terminal domain (residues 1−90) and the
rest of the polypeptide (residues 91−742) (Table S2).
Reﬁnement beyond rigid body was not carried out due to the
low resolution. Coordinates and structure factors have been
deposited in the PDB as entry 5D1Y.
Small-Angle X-ray Scattering. SAXS was performed at
the CHESS G1 station using a 10.5 keV 250 μm × 250 μm X-
ray beam. Data were collected on a Pilatus 100 K detector with
a sample-to-detector distance of 1.5 m. The transmitted
intensity was measured on a PIN diode beamstop, as previously
described.25 SAXS measurements on His6-tagged α were
performed in the standard in vitro assay buﬀer (50 mM
HEPES, pH 7.6, 15 mM MgCl2, 5% glycerol). All other SAXS
measurements were performed with untagged α or His6-tagged
β in a modiﬁed assay buﬀer (50 mM HEPES, pH 7.6, 15 mM
MgCl2, 5% glycerol, 13 mM KCl). Each α sample was prepared
by ﬁrst incubating solutions of α, CDP, and ATP (or dATP)
separately at 37 °C for 1 min, then adding CDP and ATP (or
dATP), in that order, to the α solution. The mixed solution was
then equilibrated by incubating at 37 °C for 1 min, followed
immediately by data collection. Samples containing both
subunits were prepared in a similar way, except that DTT
was added to the α stock solution to bring the ﬁnal DTT
concentration in the reaction mixture to 5 mM. CDP and ATP
(or dATP) were added to the α stock solution in the same
manner as described above. β (preincubated for 30 s at 37 °C)
was then added, and data collection was initiated within 30 s of
mixing. For every sample, a carefully matched background
solution was prepared containing all ingredients in the protein
buﬀer. Samples were loaded into an in vacuo oscillating ﬂow
cell,26 and multiple 1 and 5 s exposures were taken per sample
as previously described.27 Data collection was completed within
4 min of loading each sample. The scattering images were
integrated about the beam center and normalized by the
transmitted intensities following previously described image
correction procedures.27 Superimposable exposures that did not
display apparent radiation-induced changes were averaged.
Background scattering collected on matched buﬀer was
subtracted from the protein solution scattering to produce
the one-dimensional protein scattering proﬁle, I(q), as a
function of q, where q = 4π/λ sin θ; 2θ is the scattering
angle, and λ is the X-ray wavelength. The quality of the
background subtraction was evaluated as described previ-
ously.27
Analysis of structural parameters, singular value decom-
position analysis, and multistate ﬁtting of experimental
scattering curves were performed using custom code written
in MATLAB, as described previously.9,28 The zero-angle
scattering intensity I(0) and overall radius of gyration Rg
were obtained from a Guinier approximation (eq 1)29 to the
low q region of the scattering proﬁles. Rg and I(0) are
determined from linear ﬁts to Guinier plots, ln(I(q)) versus q2,
in the region qmax*Rg < 1.3.
≈ −I q I R q( ) (0) exp( /3)g2 2 (1)
In the case of elongated proteins (e.g., ﬁlaments), a similar
approximation can be made to I(q)*q (eq 2).29 Here, a cross-
sectional radius of gyration, Rc, can be determined from a linear
ﬁt to the cross-sectional Guinier plot, ln(I(q)*q) versus q2.
* ≈ −I q q I R q( ) (0) exp( /2)c2 2 (2)
For conformationally homogeneous samples, the pair
distance distribution function, P(r), was calculated from the
experimental I(q) with the indirect Fourier transform method29
implemented in the program GNOM.30 Low-resolution models
of protein structures were generated from the GNOM outputs
(with a high-resolution limit of qRg ≈ 8) using the ab initio
reconstruction programs DAMMIF31 and DAMMIN.32 DAM-
AVER33 was used to align ab initio models, reject outliers, and
average the remaining models to produce the most probable
model. Structural parameters and shape reconstruction statistics
are summarized in Table S3. Theoretical scattering curves were
calculated from atomic coordinates using FoXS.34 The
disordered C-terminus of α (residues 743−792) and several
other missing residues (292−293) were modeled into the
structure of the dATP-induced α6 with Modeller,
35 and
conformational sampling was performed with constant-temper-
ature molecular dynamics (300 K) in AllosMod-FoXS.36 In the
model that best ﬁt the SAXS data, the C-terminal tails were
allowed to relax and take up space within the α6 ring.
Electron Microscopy. Specimens for electron microscopy
were prepared by incubating 6 μM α with 1, 3, or 10 mM ATP
in assay buﬀer at 37 °C for 2 min followed by 20-fold dilution
in assay buﬀer containing a matched concentration of ATP.
The diluted mixture (5 μL) were applied to a thin carbon ﬁlm
supported by a 300 mesh Cu/Rh grid (Ted Pella) that had
been glow discharged immediately before use.37 The grid was
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washed three times with a stain solution containing 2% uranyl
acetate (Ted Pella) and 0.2% trehalose. A second carbon layer
was applied, excess stain blotted with ﬁlter paper, and the
specimen air-dried following standard protocols.38 Images were
acquired at 50000× magniﬁcation on a Tecnai F20 microscope
(FEI) operated at 120 kV equipped with a 4096 × 4096 pixel
CCD camera (Gatan).
■ RESULTS
Crystal Structure of the dATP-Induced Hexamer. The
subunit arrangement of the dATP-induced α6 was determined
by X-ray crystallography. Although crystallization of human α
in the presence of dATP has been documented, the structure
could not be solved due to poor diﬀraction.12 We ﬁnd that in
agreement with previous observations,12 cocrystallization of
human α with 500 μM dATP yields crystals that diﬀract to very
low resolution (∼8 Å), much of which is masked by the
beamstop in a typical macromolecular crystallography beam-
line. However, by utilizing a small beamstop to collect
diﬀraction data at low resolution, a 9-Å structure could be
solved by molecular replacement using a previously reported
human α2 structure as the search model (PDB: 3HNC)
12
(Table S2). At this low resolution, structural details such as side
chain and ligand positions cannot be inferred. However, the
subunit arrangement can be determined unambiguously (Figure
S2). The ﬁnal structure reveals a ring-shaped α6 (Figure 1B)
formed by three α2 subunits making contacts at the N-terminal
cone domains containing the activity-regulating site that binds
dATP (Figure 1B, green). Importantly, the crystal lattice giving
rise to this new structure supports only one hexameric
arrangement, one that is similar to the inward-pointing
architecture in the 6.6-Å resolution structure of the dATP-
induced α6 from S. cerevisiae RNR
12 (Figure S1A). The human
dATP-induced α6 structure also shares features with the dATP-
inhibited α4β4 complex from E. coli,
9,19 which is a ring of a
similar size with the active sites facing inward. As in the human
α6, the N-terminal cone domains are also involved in making
the subunit contacts in this E. coli structure.
dATP and ATP Produce Similar Hexamers. With the
structure of the dATP-induced human α6 determined, SAXS
was employed to compare the structural eﬀects of ATP and
dATP on human α in solution. SAXS is a solution-based
structural technique that is uniquely suited for investigating
quaternary structure under varying solution conditions,
particularly when mixtures of species may be present.9 Using
an in-vacuum oscillating ﬂow cell, scattering was measured from
α at very dilute concentrations close to the physiological range
(0.5−1 μM monomer).39 All samples contained 1 mM CDP,
the natural substrate for both ATP and dATP when bound to
the speciﬁcity site.
Titration of dATP into 4 μM α in the presence of 1 mM
CDP leads to a dramatic change in the shape of the scattering
curves and a concomitant increase in the zero-angle scattering
intensity (Figure 2A, blue to red), indicative of a large structural
change involving an increase in mass. Over the course of the
dATP titration, much of the structural change occurs at low μM
dATP. Above 8 μM dATP, the scattering curves are nearly
superimposable. The large set of scattering curves allows for the
determination of the number of interconverting species in a
model-independent manner via singular value decomposition
(SVD). Consistent with the presence of iso-scattering points
(Figure 2A), SVD produces two signiﬁcant singular vectors
(Figure S3, magenta), suggesting that the structural change
caused by dATP is an interconversion of two oligomerization
states. The initial state (at 0 μM dATP) agrees well with known
crystal structures of the dimer (Figures 1C and S5A), whereas
the ﬁnal state (above 8 μM dATP) agrees well with the crystal
structure of the human hexamer (Figures 1D and 5B).
Interestingly, although mammalian α has been reported to
dissociate in the absence of eﬀectors,13,15,16 we ﬁnd that
substrate binding is suﬃcient to induce dimerization, possibly
due to reduced conformational disorder. Linear combinations
of the scattering at 0 μM dATP and at 50 μM dATP ﬁt well to
the set of curves shown in Figure S6A, thus indicating that the
structural change caused by dATP can be described as a
dimer−hexamer transition with a midpoint near the equimolar
point (1 dATP per α) (Figure 2B). Only hexamers are
observed above 8 μM, which corresponds to the full occupancy
point (2 dATP’s per α). Importantly, intermediates, including α
tetramers, are not observed in these data.
Under identical solution conditions, ATP was titrated into 4
μM α in the presence of 1 mM CDP. Addition of ATP up to 1
mM leads to scattering curves (Figure 2D, blue to red) that are
highly similar to the set obtained from the dATP titration
experiment (Figure 2A). SVD of these ATP titration data also
yields two signiﬁcant singular vectors, indicative of a two-state
transition that is largely complete at 1 mM ATP (Figure S4,
magenta). Notably, the calculated scattering of an inverted
hexamer model in which the active sites point outward (Figure
S1B) yields a poor ﬁt to the scattering data at 1 mM ATP
(Figure S5B). In contrast, the scattering at 1 mM ATP is nearly
Figure 2. Both dATP and low ATP induce hexamerization of human
α. (A) SAXS proﬁles measured as 0−50 μM dATP is titrated into 4
μM α in the presence of 1 mM CDP (blue to red curves) display iso-
intensity points, suggesting a two-state transition. (B) Fitting linear
combinations of α2 and α6 scattering to the titration data provides
relative fractions of the two species and shows a midpoint near
equimolar [dATP]:[α]. (C) Activity in the presence of dATP is
biphasic with a loss in activity beyond equimolar [dATP]:[α]. (D)
SAXS proﬁles measured as 0−1 mM ATP is titrated into 4 μM α in
the presence of 1 mM CDP (blue to red curves) are consistent with a
two-state dimer−hexamer transition. (E) Fitting linear combinations
of α2 and α6 scattering to the titration data provides relative fractions
of the two species as a function of ATP. (F) A steady increase in
activity is observed up to 1 mM ATP and continues to slowly increase
at higher ATP.
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superimposable (up to a q value of 0.15 Å−1) with that
measured in the presence of 50 μM dATP (Figure S5B),
suggesting that ATP forms a hexamer that is indistinguishable
from the dATP-induced α6 at low resolution. Furthermore,
linear combinations of the same two scattering curves used to
ﬁt the dATP titration data also ﬁt well to the ATP titration data
(Figure S6B), indicating that sub-millimolar concentrations of
ATP cause a dimer−hexamer transition similar to that observed
with micromolar concentrations of dATP.
Instability of the ATP-Induced hexamer. Although α
hexamerization is favored up to 1 mM ATP (Figure 2D,E),
additional conformational changes are observed at higher ATP
concentrations. Increasing the ATP concentration to 10 mM in
the presence of 4 μM α and 1 mM CDP leads to an upturn in
the scattering at low q and a loss of features representing the
hexamer, such as the peak at q = 0.07 Å−1 arising from cross-
ring interference (Figure 3A). These changes are consistent
with the growth of aggregates that are highly anisotropic in
shape. Interestingly, this eﬀect is more pronounced for α
constructs with an N-terminal hexahistidine (His6) tag.
Although the tag has negligible eﬀects on the dimer−hexamer
transitions in the presence of dATP or submillimolar ATP
(Figures S3, S4), the presence of the tag leads to a greater
fraction of anisotropic aggregates at >1 mM ATP. In fact, the
scattering from 4 μM His6-tagged α displays a total loss of
features at 10 mM ATP and can be approximated as a highly
elongated species with a cross-sectional radius of gyration (Rc)
of 28.1 Å (Figure S5C). In agreement with the SAXS data,
electron micrographs of 0.3 μMHis6-tagged α incubated with 1,
3, and 10 mM ATP illustrate the progressive conversion of
hexamers to prominent ﬁlaments (Figure 3B). The formation
of ﬁlaments would explain previous observations of aggrega-
tion-like behavior in eukaryotic α occurring in the presence of
ATP.16 Whereas a loss of scattering features is observed at
millimolar concentrations of ATP (Figure 3A), these features
become more deﬁned when dATP is added to 4 μM α in the
presence of 3 mM ATP (Figure 3C), suggesting that the
ﬁlament formation is reversible. Together, these results
demonstrate that the ATP-induced α6 can readily interconvert
with other conformational states, whereas dATP favors the
hexameric form.
Activity in the Presence of dATP and ATP. In an eﬀort
to correlate oligomerization with the speciﬁc activity of α,
dCDP formation was measured as a function of dATP and ATP
in the presence of 4 μM α, a 5-fold excess of β, 0.5 mM [5-3H]-
CDP, human thioredoxin, and human thioredoxin reductase.
To prevent precipitation of the subunits at these high
concentrations, the assay buﬀer was modiﬁed with the addition
of 150 mM KCl. In the absence of dATP or ATP, we ﬁnd that
turnover occurs at a very low rate of 0.080 ± 0.014 s−1 (initial
points in Figure 2C,F). Titration of dATP leads to a 3.2-fold
increase up to 4 μM dATP (equimolar with α), followed by a
steady decrease to 0.045 ± 0.007 s−1 at 16 μM dATP (Figure
2C). On the basis of previously reported dissociation constants
of 0.07 and 1.5 μM for dATP binding to the speciﬁcity and
activity sites, respectively, in murine RNR,40 our observation of
biphasic behavior in activity can be attributed to dATP ﬁrst
binding the speciﬁcity site, which stimulates CDP reduction,
followed by dATP binding to the activity-regulating site causing
inhibition. In contrast, titration of ATP leads to a steady
increase in turnover up to 3 mM ATP (Figure 2F), and then
maintenance of this high level of activity out to 10 mM ATP
(Figure S7), the maximum concentration of ATP we tested.
This trend in activity data is as expected from a positive eﬀector
and is consistent with recent work on murine RNR.16
Before comparing these activity data collected in the
presence of both α and β (both subunits are required for
activity) with oligomeric state data on α alone, the inﬂuence of
β on the oligomeric state of α must be established. If, in the
presence of dATP, β has no eﬀect on the oligomeric state of α,
then Figure 2 data can be interpreted as indicating that α6
formation and inhibition are correlated (Figure 2B,C). As we
describe below, we ﬁnd this correlation to be valid in the case of
dATP. In the presence of ATP, however, we show below that
the presence of β does aﬀect the oligomeric state of α, and thus
we cannot deﬁnitively say based on Figure 2E,F data that ATP-
induced α6 are active.
β Has a Large Eﬀect on the Structure of α Oligomers
in the Presence of ATP, but Not in the Presence of
dATP. To address the aﬀect of β on the structures of α
oligomers, we prepared multiple-turnover reaction mixtures of
the two subunits under both activating (3 mM ATP, 1 mM
CDP, 5 mM DTT) and inhibiting conditions (50 μM dATP, 1
mM CDP, 5 mM DTT). Scattering was then measured
immediately after a short incubation of the reaction mixtures.
Here, DTT was used to reduce the redox active cysteines in α
that are oxidized during each turnover. Under the activating
conditions (3 mM ATP, 1 mM CDP, 5 mM DTT), we expect
∼25% of the CDP to be converted to dCDP during the course
of the SAXS measurement. As no changes in scattering were
observed during the course of data collection, this low level of
turnover does not appear to aﬀect the structure or background
scattering to an appreciable extent.
We ﬁnd that addition of β2 to α under inhibiting conditions
(50 μM dATP, 1 mM CDP, 5 mM DTT) leads to a scattering
curve (Figure 4A, red) that is greater in overall intensity but
Figure 3. High ATP induces a third α oligomerization state. (A) SAXS
proﬁles measured from 4 μM α in the presence of 1 mM CDP and
high ATP (1−10 mM) display changes in scattering (blue to red
curves) that can be attributed to the conversion of hexamers into a
highly elongated species. (B) Electron micrographs of 0.3 μM His6-
tagged α in 1, 3, and 10 mM ATP show the conversion from primarily
hexamers to ﬁlaments. The scale bar corresponds to 50 nm. (C) The
SAXS proﬁle measured from 4 μM α in 3 mM ATP, 1 mM CDP
(blue) becomes more deﬁned when 50 μM dATP is added to the mix
(red) and becomes superimposable with that of 4 μM α in 50 μM
dATP, 1 mM CDP (black dotted). Although subtle, the change in
scattering is consistent with the reversal of ﬁlaments into hexamers.
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otherwise highly similar to that of the dATP-induced α6 ring
alone (Figure 4A, black). Notably the peak at q ≈ 0.07 Å−1,
which arises from the ring-shaped hexameric arrangement,
remains unperturbed and thus suggests that the dATP-induced
α6 ring maintains its shape even with the addition of β2.
Interestingly, the scattering under these conditions (Figure 4A,
red) cannot be explained as a simple sum of the scattering from
the α6 ring (Figure 4A, black) and free β2 (Figure 4A, green),
indicating that the two subunits associate. In particular, a 1.6-
fold increase is observed in the forward scattering intensity or
I(0), which is larger than the expected value of 1.1 in the case
where β2 cannot associate with the dATP-induced α6 ring but is
smaller than the expected value of 2.3 in the case where three
copies of β2 fully associate with the α6 ring to form a
homogeneous solution of α6β6. These results indicate that some
fraction of β2 is associated with the dATP-induced α6 ring,
which is consistent with previous GEMMA results that suggest
a dATP-induced α6β2 species in murine RNR
16 as well as an
EM reconstruction of a dATP-induced species from S. cerevisiae
RNR in which a single copy of β2 appears bound to the α6
ring.12 Although in this S. cerevisiae RNR structure β2 appeared
to be inside the ring, our data on the human protein in solution
is not consistent with an interior binding site for β2. In
particular, we observe an increase in radius of gyration (Rg)
from 72.9 ± 1.7 to 79.3 ± 3.0 Å with the addition of β2 (Figure
S8), which cannot be explained by the formation of a α6β2
complex, in which β2 is bound within the ring as the
predominant species. As Rg represents the root-mean-square
distance of all electrons in a particle, binding of β2 to the
interior of the α6 ring would lead to an overall decrease in
apparent Rg, and this value would be further reduced by the
presence of any unbound β2. Thus, although we cannot
deﬁnitively identify a single structure for the inhibited complex
as the scattering from our dATP sample likely contains both
free and associated β2, we can say that an α6β2 state with β2
outside the ring is a likely component (Figure 4B).
In contrast to the small changes observed when β is added to
dATP-inhibited hexamers (black to red curves in Figure 4A),
the addition of 4 μM β to 4 μM α in the presence of ATP leads
to a dramatically diﬀerent scattering curve (Figure 4A, blue
dotted). As in the case of the ATP-induced ﬁlaments, here, we
see an upturn at low q and a loss of scattering features,
indicating that there is aggregation-like behavior involving
highly anisotropic species. Although β2 may bind to α ﬁlaments,
any scattering from smaller species (such as α2β2) would be
masked by the presence of aggregates, which scatter more
strongly. Thus, we cannot unambiguously identify the active
form. However, comparing the eﬀects of the two activity-
regulating eﬀectors leads to the important observation that the
dATP-induced α6 maintains its shape in the presence of the β
subunit, whereas the ATP-induced α6 does not (Figure 4B).
This diﬀerence may explain why both eﬀectors can form similar
hexameric rings and produce diﬀerent outcomes in activity.
■ DISCUSSION
Since the ﬁrst observations of nucleotide-dependent oligome-
rization in pioneering studies of class Ia RNRs,20−23,41 studies
by Cooperman and co-workers have spurred renewed interest
in elucidating its role in allosteric activity regulation.9−16,19,42
These studies have shown that eukaryotic RNRs form a
diﬀerent set of quaternary structures than the E. coli class Ia
RNR and, in particular, demonstrate the need to better resolve
the oligomerization states of the α subunit. In this present
study, we used solution-based SAXS to monitor the conforma-
tional changes of human α as a function of ATP and dATP.
Because scattering is additive at the dilute protein concen-
trations used in SAXS, the large data sets generated by the
titration experiments allow for model-independent SVD
analysis. From this analysis, we ﬁnd that dATP induces a
dimer−hexamer transition with no tetramer intermediate. In
addition, a similar dimer−hexamer transition is seen at sub-
millimolar ATP. Furthermore, both ATP and dATP induce a
ring-shaped hexamer that is consistent with our low-resolution
X-ray crystal structure (Figure 1B). Although structurally
similar, however, the dATP-induced α6 and the ATP-induced
α6 diﬀer in their relative stabilities. Whereas the latter is easily
disrupted by the presence of the β subunit or by high
concentrations of ATP, the former maintains its ring structure
even when β subunit is added.
Figure 4. Human β can alter the structure of α oligomers substantially in the presence of activating eﬀector, ATP, but not in the presence of dATP.
(A) The dATP-induced α6 (black) is represented by the SAXS proﬁle of 4 μM α in 50 μM dATP, 1 mM CDP. Addition of equimolar β to 4 μM α
under inhibitory conditions (50 μM dATP, 1 mM CDP, 5 mM DTT) results in scattering (red) that shares similar features as that of the dATP-
induced α6 (black). In contrast, addition of equimolar β to 4 μM α under activating conditions (3 mM ATP, 1 mM CDP, 5 mM DTT) leads to
scattering (blue dotted) that deviates greatly from that of the dATP-induced α6 (black). For reference, the scattering from 16 μM β in 1 mM CDP is
shown in green, normalized by a factor of 4 to facilitate comparison with other curves. (B) Model for the diﬀerential ability of human β to aﬀect the
oligomeric state of human α. In human RNR, both ATP and dATP can promote the formation of ring-shaped α6 in the absence of β2. β2 cannot
disrupt the dATP-induced α6 and hence has poor access to the active sites lining the interior of the ring-shaped α6. By contrast, addition of β2 can
disrupt the ATP-induced α6 ring. Although the active conformation is not yet known, it is plausible that the increased dynamics under active
conditions allows for greater access of β2 to the active sites.
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The inability to detect tetramers between the dimeric and
hexameric forms of α in our SAXS data would at ﬁrst seem to
contradict previous observations. Seminal studies performed on
RNR subunits puriﬁed from Ehrlich tumor cells and calf
thymus were the ﬁrst to show that both dATP and ATP can
produce higher order oligomers of α.20,21,41 In these studies,
less generalized forms of the Svedberg equation were used to
estimate mass from the sedimentation coeﬃcients (s20,w),
leading to its underestimation. Speciﬁcally, use of the Atassi-
Gandhi approximation to the Svedberg equation43 led to a
tetrameric mass assignment to a 15.2 S species observed in calf
thymus RNR treated with dATP.21 In the case of murine RNR,
use of the Svedberg equation for a smooth sphere44 again led to
the assignment of a tetrameric mass for the 16 S species
observed in the presence of dATP and a hexameric mass for a
broad 23 S peak observed in the presence of ATP.11,13
However, both equations only apply to highly globular proteins.
With the structural data now available from this work and
others,10,12 we know that α oligomers cannot be approximated
as such. Using modern software for hydrodynamic calcu-
lations,45 we ﬁnd that the ring-shaped hexamer observed in our
crystal structure has a theoretical s20,w value of ∼16 S. This
result strongly suggests that the previously observed 15−16 S
species likely arose from ring-shaped α hexamers, whereas
higher s20,w values would be consistent with our observations of
α ﬁlament formation. Use of structural information in
hydrodynamic calculations thus brings consensus to previously
inconsistent observations.
With the absence of tetramers established in eukaryotic
RNRs, we ﬁnd that a major structural diﬀerence in human RNR
observed with ATP or dATP is in the relative stabilities of α6
rings. Despite diﬀerences in quaternary structure, our
observations with human RNR are reminiscent of our previous
observations with the E. coli class Ia RNR (Figure 5). In E. coli
RNR, dATP is uniquely able to stabilize a single species: the
ring-shaped α4β4 complex (Figure 5).
9 Furthermore, due to its
transient nature, the active α2β2 complex in E. coli RNR readily
interconverts with other species, including α4β4, under
activating conditions.9,14 Similarly, our results suggest that the
α6 ring forms the basis of the allosterically inhibited form of
human RNR and that this species is able to interconvert with
other species in the presence of ATP (Figure 5). Indeed,
contrary to previously reported electron micrographs of the S.
cerevisiae RNR (EM DataBank entry 1807), in which β2
appeared to bind the interior of the α6 ring,
12 our SAXS
results suggest that such a conﬁguration is not likely to be
predominant in dATP-inhibited human RNR. We instead
propose that the interior α6 ring is largely inaccessible to β2,
particularly if we account for the presence of functionally
essential tails in both subunits that are disordered and thus not
visible in existing crystal structures. Modeling the disordered C-
terminal tails of α within the α6 ring not only reduces the
accessibility of the active sites, but also further improves the
agreement between the theoretical and experimental scattering
(Figure S9 and Supporting Information). Our results thus
suggest that in both E. coli and human RNR, allosteric
inhibition entails keeping β2 away from catalytic positions on α,
either by forming a ring structure with β to hold it “at arm’s
length” or by forming a ring without β, such that β is excluded
(Figure 5). Although the oligomeric states involved are not
conserved between these two RNR species, the net result is the
same: β is prevented from providing a radical species necessary
to initiate catalysis in the active site of α.
Our results serve to elucidate the structural basis of allosteric
inhibition in human RNR, and at the same time, raise a number
of fascinating questions. Speciﬁcally, we observe mixtures of
species in the presence of both subunits and ATP, some or all
of which could be physiologically relevant and/or catalytically
active. Although the physiological relevance of α ﬁlaments
remains to be seen, with the recent visualization of ﬁlamentous
states of CTP synthetase and IMP dehydrogenase in cells,46,47 a
case can be made for exploring whether ﬁlaments observed in
vitro can also exist in vivo. Understanding the relevance of
RNR oligomeric states as well as the kinetics of structural
interconversions will ultimately be essential for understanding
RNR function. With the recent progress made for eukaryotic
RNRs from this work and others,10−12,15,16 we are entering a
new phase of discovery into this complex class of enzymes.
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